98-17412. Indirect Food Additives: Adjuvants, Production Aids, and Sanitizers  

  • [Federal Register Volume 63, Number 126 (Wednesday, July 1, 1998)]
    [Rules and Regulations]
    [Pages 35798-35799]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-17412]
    
    
    =======================================================================
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    21 CFR Part 178
    
    [Docket No. 97F-0305]
    
    
    Indirect Food Additives: Adjuvants, Production Aids, and 
    Sanitizers
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Final rule.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is amending the food 
    additive regulations to provide for the expanded safe use of siloxanes 
    and silicones; cetylmethyl, dimethyl, methyl 11-methoxy-11-oxoundecyl 
    as a pigment dispersant in all pigmented polymers intended for use in 
    contact with food. This action is in response to a petition filed by 
    Goldschmidt Chemical Corp.
    
    DATES: The regulation is effective July 1, 1998; written objections and 
    requests for a hearing by July 31, 1998.
    
    ADDRESSES: Submit written objections to the Dockets Management Branch 
    (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, 
    Rockville, MD 20857.
    
    FOR FURTHER INFORMATION CONTACT: Vir D. Anand, Center for Food Safety 
    and Applied Nutrition (HFS-216), Food and Drug Administration, 200 C 
    St. SW., Washington, DC 20204, 202-418-3081.
    
    SUPPLEMENTARY INFORMATION: In a notice published in the Federal 
    Register of July 31, 1997 (62 FR 41053), FDA announced that a food 
    additive petition (FAP 7B4550) had been filed by Goldschmidt Chemical 
    Corp., c/o Keller and Heckman, 1001 G St. NW., suite 500 West, 
    Washington, DC 20001. The petition proposed to amend the food additive 
    regulations in Sec. 178.3725 Pigment dispersants (21 CFR 178.3725) to 
    provide for the expanded safe use of siloxanes and silicones; 
    cetylmethyl, dimethyl, methyl 11-methoxy-11-oxoundecyl as a pigment 
    dispersant in all pigmented polymers intended for use in contact with 
    food.
        FDA has evaluated data in the petition and other relevant material. 
    Based on this information, the agency concludes that the proposed use 
    of the additive is safe, that the additive will achieve its intended 
    technical effect, and therefore, that the regulations in Sec. 178.3725 
    should be amended as set forth below.
        Information in the petition indicates that one of the constituents 
    of the additive, i.e., hexadecene which is a starting material for the 
    additive, leads to the formation in rabbits of a transient metabolite, 
    1,2-epoxyhexadecane (EHD). In a published study, EHD was reported to be 
    a weak skin carcinogen in female Swiss mice (Ref. 1). FDA evaluated 
    this study (Ref. 2) and has concluded that the evidence that EHD may be 
    a weak dermal carcinogen in female Swiss mice does not preclude a 
    conclusion that the petitioned use of the substance is safe\1\.
    ---------------------------------------------------------------------------
    
        \1\ As noted, EHD is reported to be a weak skin carcinogen in 
    female Swiss mice. This finding does not mean that EHD is a 
    carcinogenic impurity of the additive.
        If EHD were a carcinogenic impurity, FDA would evaluate such 
    impurity under the general safety clause, using risk assessment 
    procedures to determine whether there is a reasonable certainty of 
    no harm that would result from the proposed use of the additive, 
    Scott v. FDA, 728 F. 2d 322 (6th Cir. 1984).
    ---------------------------------------------------------------------------
    
        First, the incidence of dermal tumors in EHD-treated mice was small 
    (2 or 3 of 40 mice) and not statistically significant, assuming that 
    control animals had no dermal tumors. Second, there were deficiencies 
    in the conduct and reporting of this study. Third, dermal 
    carcinogenicity is not highly predictive of carcinogenicity by other 
    routes of exposure (Ref. 3). These observations support the agency's 
    view that there is no evidence that suggests that EHD is likely to be a 
    carcinogen when orally ingested, which is the route of exposure most 
    directly relevant to the safety assessment of food additives.
        In accordance with Sec. 171.1(h) (21 CFR 171.1(h)), the petition 
    and the documents that FDA considered and relied upon in reaching its 
    decision to approve the petition are available for inspection at the 
    Center for Food Safety and Applied Nutrition by appointment with the 
    information contact person listed above. As provided in Sec. 171.1(h), 
    the agency will delete from the documents any materials that are not 
    available for public disclosure before making the documents available 
    for inspection.
        The agency has determined under 21 CFR 25.31(i) that this action is 
    of a type that does not individually or cumulatively have a significant 
    effect on the human environment. Therefore, neither an environmental 
    assessment nor an environmental impact statement is required.
        This final rule contains no collections of information. Therefore, 
    clearance by the Office of Management and Budget under the Paperwork 
    Reduction Act of 1995 is not required.
        Any person who will be adversely affected by this regulation may at 
    any time on or before July 31, 1998, file with the Dockets Management 
    Branch (address above) written objections thereto. Each objection shall 
    be
    
    [[Page 35799]]
    
    separately numbered, and each numbered objection shall specify with 
    particularity the provisions of the regulation to which objection is 
    made and the grounds for the objection. Each numbered objection on 
    which a hearing is requested shall specifically so state. Failure to 
    request a hearing for any particular objection shall constitute a 
    waiver of the right to a hearing on that objection. Each numbered 
    objection for which a hearing is requested shall include a detailed 
    description and analysis of the specific factual information intended 
    to be presented in support of the objection in the event that a hearing 
    is held. Failure to include such a description and analysis for any 
    particular objection shall constitute a waiver of the right to a 
    hearing on the objection. Three copies of all documents shall be 
    submitted and shall be identified with the docket number found in 
    brackets in the heading of this document. Any objections received in 
    response to the regulation may be seen in the Dockets Management Branch 
    between 9 a.m. and 4 p.m., Monday through Friday.
        The following references have been placed on display in the Dockets 
    Management Branch (address above) and may be seen by interested persons 
    between 9 a.m. and 4 p.m., Monday through Friday.
        1. Van Duuren, B. L., L. Langseth, B. M. Goldschmidt, and L. 
    Orris, ``Carcinogenicity of Epoxides, Lactones, and Epoxy Compounds. 
    VI. Structure and Carcinogenic Activity,'' Journal of the National 
    Cancer Institute, vol. 39, No. 6., pp. 1217-1228, 1967.
        2. Memorandum from Executive Secretary of the Cancer Assessment 
    Committee, FDA, to Quantitative Risk Assessment Committee, FDA, 
    concerning ``Potential Carcinogenicity of 1,2-epoxyhexadecane (EHD): 
    Subject of Food Additive Petition No. 7B4550 (Goldschmidt Chemical 
    Corp.),'' dated January 8, 1998.
        3. Tobin, Paul S. et al., ``An Evaluation of Skin Painting 
    Studies as Determinants of Tumorigenesis Potential Following Skin 
    Contact with Carcinogens,'' Regulatory Toxicology and Pharmacology, 
    vol. 2, 22-37, 1982.
    
    List of Subjects in 21 CFR Part 178
    
        Food additives, Food packaging.
        Therefore, under the Federal Food, Drug, and Cosmetic Act and under 
    authority delegated to the Commissioner of Food and Drugs, 21 CFR part 
    178 is amended as follows:
    
    PART 178--INDIRECT FOOD ADDITIVES: ADJUVANTS, PRODUCTION AIDS, AND 
    SANITIZERS
    
        1. The authority citation for 21 CFR part 178 continues to read as 
    follows:
    
        Authority: 21 U.S.C. 321, 342, 348, 379e.
        2. Section 178.3725 is amended in the table by alphabetically 
    adding an entry under the headings ``Substances'' and ``Limitations'' 
    to read as follows:
    
    
    Sec.  178.3725  Pigment dispersants.
    
     * * * * *
    
                                                                                                                    
    ----------------------------------------------------------------------------------------------------------------
                           Substances                                              Limitations                      
    ----------------------------------------------------------------------------------------------------------------
      *                    *                    *                    *                    *                    *    
                                                                 *                                                  
    Siloxanes and silicones; cetylmethyl, dimethyl, methyl   For use only at levels not to exceed 0.5 percent by    
     11-methoxy-11-oxoundecyl (CAS Reg. No. 155419-59-3).     weight of the pigment. The pigmented polymers may     
                                                              contact all foods under conditions of use C, D, E, F, 
                                                              and G described in Table 2 of Sec.  176.170(c) of this
                                                              chapter.                                              
    ----------------------------------------------------------------------------------------------------------------
    
    
        Dated: June 19, 1998.
    William K. Hubbard,
    Associate Commissioner for Policy Coordination.
    [FR Doc. 98-17412 Filed 6-30-98; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Effective Date:
7/1/1998
Published:
07/01/1998
Department:
Food and Drug Administration
Entry Type:
Rule
Action:
Final rule.
Document Number:
98-17412
Dates:
The regulation is effective July 1, 1998; written objections and requests for a hearing by July 31, 1998.
Pages:
35798-35799 (2 pages)
Docket Numbers:
Docket No. 97F-0305
PDF File:
98-17412.pdf
CFR: (1)
21 CFR 178.3725